Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Sell
25,804
-8,396
-25% -$391K 0.02% 340
2025
Q4
$1.66M Buy
34,200
+1,067
+3% +$52.9K 0.03% 262
2025
Q3
$1.56M Sell
33,133
-7,136
-18% -$344K 0.02% 267
2025
Q2
$1.95M Sell
40,269
-2,704
-6% -$138K 0.03% 209
2025
Q1
$2.38M Buy
42,973
+4,773
+12% +$258K 0.05% 157
2024
Q4
$1.84M Buy
38,200
+853
+2% +$43.4K 0.03% 186
2024
Q3
$2.15M Buy
37,347
+2,647
+8% +$143K 0.04% 165
2024
Q2
$1.68M Buy
34,700
+1,190
+4% +$57.4K 0.03% 190
2024
Q1
$1.63M Buy
33,510
+3,026
+10% +$148K 0.03% 204
2023
Q4
$1.52M Sell
30,484
-4,837
-14% -$237K 0.04% 201
2023
Q3
$1.89M Buy
35,321
+5,010
+17% +$267K 0.05% 138
2023
Q2
$1.63M Buy
30,311
+1,240
+4% +$66.7K 0.04% 158
2023
Q1
$1.58M Buy
29,071
+3,758
+15% +$183K 0.04% 157
2022
Q4
$1.23M Buy
25,313
+4,671
+23% +$205K 0.04% 191
2022
Q3
$785K Sell
20,642
-3,102
-13% -$138K 0.03% 241
2022
Q2
$1.19M Buy
23,744
+2,350
+11% +$125K 0.04% 159
2022
Q1
$1.1M Buy
21,394
+1,681
+9% +$86.8K 0.03% 193
2021
Q4
$988K Sell
19,713
-1,221
-6% -$60.4K 0.03% 217
2021
Q3
$1.01M Sell
20,934
-275
-1% -$14K 0.03% 196
2021
Q2
$1.12M Buy
21,209
+5,227
+33% +$273K 0.04% 170
2021
Q1
$790K Buy
15,982
+1
+0% +$48 0.03% 212
2020
Q4
$777K Sell
15,981
-955
-6% -$47.1K 0.04% 181
2020
Q3
$850K Buy
16,936
+213
+1% +$11K 0.05% 149
2020
Q2
$854K Buy
16,723
+706
+4% +$34.3K 0.05% 136
2020
Q1
$700K Buy
16,017
+757
+5% +$36.2K 0.06% 138
2019
Q4
$766K Buy
15,260
+1,259
+9% +$59K 0.06% 155
2019
Q3
$649K Buy
14,001
+2,507
+22% +$108K 0.05% 157
2019
Q2
$497K Sell
11,494
-2,404
-17% -$102K 0.04% 178
2019
Q1
$615K Sell
13,898
-828
-6% -$35.5K 0.05% 146
2018
Q4
$639K Buy
14,726
+2,705
+23% +$119K 0.06% 139
2018
Q3
$537K Buy
12,021
+1,755
+17% +$75K 0.05% 183
2018
Q2
$411K Buy
10,266
+2,486
+32% +$97.9K 0.05% 215
2018
Q1
$312K Buy
7,780
+988
+15% +$41.1K 0.04% 231
2017
Q4
$292K Sell
6,792
-114
-2% -$5.26K 0.04% 241
2017
Q3
$344K Buy
6,906
+213
+3% +$10.3K 0.05% 180
2017
Q2
$321K Sell
6,693
-5,176
-44% -$247K 0.05% 175
2017
Q1
$537K Buy
11,869
+6,154
+108% +$261K 0.08% 109
2016
Q4
$231K Sell
5,715
-1,205
-17% -$47.5K 0.04% 191
2016
Q3
$264K Buy
6,920
+3,440
+99% +$138K 0.04% 184
2016
Q2
$146K Buy
3,480
+490
+16% +$20.1K 0.02% 228
2016
Q1
$120K Buy
2,990
+32
+1% +$1.29K 0.02% 231
2015
Q4
$126K Sell
2,958
-428
-13% -$19.7K 0.02% 204
2015
Q3
$161K Buy
3,386
+2,874
+561% +$146K 0.04% 156
2015
Q2
$25K Buy
512
+282
+123% +$14.3K 0.01% 431
2015
Q1
$11K Buy
230
+18
+8% +$861 ﹤0.01% 521
2014
Q4
$10K Buy
212
+168
+382% +$8.15K ﹤0.01% 502
2014
Q3
$2K Hold
44
﹤0.01% 599
2014
Q2
$2K Hold
44
﹤0.01% 718
2014
Q1
$2K Sell
44
-528
-92% -$26.7K ﹤0.01% 635
2013
Q4
$31K Buy
572
+535
+1,446% +$27.6K 0.01% 286
2013
Q3
$2K Hold
37
﹤0.01% 548
2013
Q2
$2K Buy
+37
New +$1.97K ﹤0.01% 470

Other funds holding SNY

SignatureFD's SNY Position: Q1 2026 in Review

SignatureFD reduced its Sanofi (SNY) stake by 25% in Q1 2026, selling an estimated $391K and leaving 25,804 shares worth $1.24M. The position accounts for 0.02% of the portfolio, ranked #340.

SignatureFD first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.38M in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • SignatureFD held 25,804 shares of Sanofi worth $1.24M as of Q1 2026.
  • SignatureFD sold 8,396 Sanofi shares in Q1 2026, an estimated $391K.
  • Sanofi made up 0.02% of SignatureFD's portfolio in Q1 2026, its #340 holding.
  • SignatureFD first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • SignatureFD's Sanofi position peaked at $2.38M in Q1 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.